Global Law Office
Client SatisfactionLawyers
Li Su
- Phone86-10-6584-6521
- Email[email protected]
- Profilewww.glo.com.cn
Position
Ms. Su is a partner based in our Beijing office specializing in corporate compliance risk control, which includes compliance review, internal control, risk assessment, data management and compliance review, crisis incident handling, compliance policy formulation, auditing, finance, corporate antitrust, anti-fraud, anti-commercial bribery, anti-unfair competition investigation, and anti-money laundering, etc.
Ms. Su is experienced in identifying non-compliance issues and regulatory risks, streamlining reporting system, and developing effective compliance measures. She also has considerable experience of assisting clients to intervene and make response plans when a crisis event occurs, and assisting companies to develop operational early warning mechanisms.
Ms. Su has provided perennial legal advisory services and special legal advisory services to many enterprises, institutions and foreign-invested enterprises. She has completed nearly 100 compliance risk control projects and litigation projects. These projects cover a wide range of industries, including fintech, securities, funds, internet finance, big data, financial services, healthcare, manufacturing, shipping, energy, telecommunications, food, and real estate.
Ms. Su has represented many civil litigations, criminal charges, and criminal defense projects.
Ms. Su is good at handling company control disputes, Sino-foreign cooperation disputes, investment and financing disputes, intellectual property disputes, company liquidation, bankruptcy, family disputes and labor dispute resolution. Ms. Su also has extensive experience in the area of criminal litigation. She has successfully helped clients to obtain immunity from prosecution, decision of not guilty, suspension of sentence and commutation of punishment.
Ms. Su has represented various multinational clients, Chinese State-owned and private companies, such as SASAC, HP, CR, Boehringer Ingelheim, Qiming Ventures, New Alliance Capital, Tai Kang, GeneScience Pharma, YeePay, AmoyDx, Bohai Securities, and etc.
Education
2006-2009 University of International Business and Economics, JM
2001-2005 Hohai University, Bachelor of Accounting